- A physician suspects a patient has a primary infection with Epstein-Barr virus (EBV). An acute serum sample, taken 5 days after symptom onset, shows an IgG titer of 1:20. A second, convalescent serum sample is collected 3 weeks later and tested in parallel. Which convalescent titer result would be most indicative of a current, primary EBV infection?
Answer: 1:80
A diagnosis of a current or recent primary infection is typically confirmed by seroconversion (going from negative to positive) or by demonstrating a significant rise in antibody titer between acute and convalescent phase sera. A four-fold or greater increase in titer is generally considered diagnostically significant. A rise from 1:20 to 1:80 represents a four-fold increase (80/20 = 4) and strongly indicates a primary infection. A titer of 1:40 is only a two-fold rise, which is not typically considered significant. A stable titer of 1:20 or a negative result would not support a diagnosis of a current primary infection.
- An enzyme immunoassay (EIA) result is reported as an index value, calculated by dividing the patient sample's optical density (OD) by the OD of the kit's cut-off calibrator. An index value greater than 1.0 is considered reactive. A patient's sample has an OD of 0.960. The cut-off calibrator OD for the run is 0.240. The negative control OD is 0.080. How should this result be interpreted?
Answer: Positive, with an index value of 4.0.
When you encounter EIA index value calculations, remember that the index is simply the patient's optical density divided by the cut-off calibrator's optical density. This standardizes results across different test runs.
Let's calculate the index value: Cut-off Calibrator ODPatient OD=0.2400.960=4.0
Since the index value of 4.0 is greater than 1.0, this result is positive (reactive). The answer is D.
Now let's examine why the other options are incorrect:
Option A misunderstands what gets compared to 1.0. You don't compare the raw patient OD (0.960) to 1.0; you compare the calculated index value (4.0) to 1.0. This is a common trap that catches students who skip the calculation step.
Option B incorrectly suggests the negative control should be used in the index calculation. The negative control (0.080) serves as a quality control measure to ensure the assay is working properly, but it's not part of the index formula. Only the patient OD and cut-off calibrator OD are used.
Option C calls this "equivocal," but an index of 4.0 is definitively positive—it's four times above the threshold, not borderline at all. This option might tempt students who focused on the patient's raw OD being below 1.0 instead of calculating the actual index.
Always perform the mathematical calculation first in EIA problems. The index value, not the raw optical density, determines the final interpretation. - A complement fixation test is performed to detect antibodies against Rickettsia rickettsii. The patient's heat-inactivated serum is first incubated with Rickettsia antigen and a standardized amount of complement. Then, antibody-coated sheep red blood cells (indicator system) are added. If the patient's serum lacks antibodies to Rickettsia, what is the expected outcome after the second incubation?
Answer: Lysis of the sheep RBCs, because complement was not fixed by the primary reaction.
This question describes a negative result in a complement fixation test. If the patient's serum does not contain antibodies to the Rickettsia antigen, no antigen-antibody complexes will form in the first step. Therefore, the added complement remains free and active in the solution. When the indicator system (antibody-coated sheep RBCs) is added, the free complement will bind to these complexes and activate the classical pathway, leading to the lysis of the sheep red blood cells. A positive result (patient has antibodies) would result in 'fixation' of complement in the first step, leaving none to lyse the indicator cells.
- Based on the passage, what pattern of precipitin lines would be expected to form in the agar after incubation?
Answer: Two separate precipitin lines that cross each other between the wells, indicating non-identity.
When you encounter Ouchterlony double immunodiffusion questions, focus on understanding what happens when different antigens interact with polyclonal antisera containing multiple antibodies.
In this setup, the center well contains polyclonal antiserum with antibodies against both HSA and human IgG - two completely different proteins. Well 1 has HSA, and well 2 has human IgG. Since these are distinct antigens with no shared epitopes, each will form independent precipitin lines with their respective antibodies from the center well.
The correct pattern shows two separate precipitin lines that cross each other, demonstrating non-identity. One line forms between the center well and well 1 (HSA-anti-HSA complex), while another forms between the center well and well 2 (IgG-anti-IgG complex). These lines cross because they represent completely different antigen-antibody reactions with no immunological relationship.
Choice A is wrong because a fused line indicates identity - meaning the same antigen in both outer wells, which isn't the case here. Choice B incorrectly suggests no reaction between the antiserum and IgG, but the polyclonal serum contains anti-IgG antibodies that will definitely react. Choice C describes partial identity with spur formation, which occurs when antigens share some but not all epitopes - again, not applicable since HSA and IgG are completely different proteins.
Remember: crossing lines = non-identity (different antigens), fused lines = identity (same antigen), and spurred lines = partial identity (related antigens). The key is recognizing what antigens you're comparing.
- A researcher wishes to design a highly specific and sensitive immunoassay to quantify a specific cytokine (antigen) in cell culture supernatants. They have two distinct monoclonal antibodies (mAb1, mAb2) that bind to separate, non-overlapping epitopes on the cytokine. Which assay format would be most appropriate for this task?
Answer: A sandwich ELISA, using mAb1 to coat the plate for capture and enzyme-conjugated mAb2 for detection.
The sandwich ELISA is the ideal format for specifically detecting and quantifying an antigen present in a complex mixture like a cell culture supernatant. It uses two different antibodies that bind to distinct epitopes. The capture antibody (mAb1) immobilizes the antigen from the sample, and the labeled detection antibody (mAb2) provides specificity and the signal for quantification. This two-site recognition makes the assay highly specific. An indirect ELISA detects antibodies, not antigens. A competitive ELISA could work but is often less sensitive than a sandwich ELISA. Using the same mAb for capture and detection is generally not feasible unless the antigen has multiple identical, repeating epitopes.
- A sandwich immunoassay for a serum tumor marker yields an unexpectedly low result for a patient with a very high tumor burden confirmed by imaging. Suspecting an issue, the technician dilutes the serum 1:100 and re-runs the assay, which now produces an extremely high, off-scale result. What is the most likely cause of the initial falsely low reading?
Answer: A high-dose hook effect due to an excess of the tumor marker antigen.
This is a classic example of the high-dose hook effect, a phenomenon that can occur in one-step sandwich immunoassays. When the antigen concentration is extremely high, it saturates both the solid-phase capture antibodies and the labeled detection antibodies simultaneously. This prevents the formation of the 'sandwich' (capture Ab-Ag-detection Ab), as few or no detection antibodies can bind to antigen that is already captured. The unbound detection antibodies are washed away, leading to a falsely low signal. Diluting the sample brings the antigen concentration back into the assay's working range, allowing the sandwich to form correctly and revealing the true high concentration.
- A patient's serum gives a false-positive result in a sandwich ELISA for a viral antigen. The patient has no symptoms or other evidence of infection. Further investigation reveals the presence of human anti-mouse antibodies (HAMA) in the patient's serum from a previous monoclonal antibody therapy. How do HAMA typically cause this type of interference?
Answer: By cross-linking the murine-derived capture and detection antibodies in the absence of antigen.
Human anti-mouse antibodies (HAMA) are a type of heterophile antibody that can interfere with two-site sandwich immunoassays that use mouse monoclonal antibodies. HAMA can simultaneously bind to the Fc portion of the mouse capture antibody on the solid phase and the Fc portion of the mouse detection antibody. This cross-linking action forms a complete 'sandwich' and generates a signal even when no antigen is present, leading to a false-positive result.
- A new rapid antigen detection test for a respiratory virus is evaluated against the gold standard PCR. Among 300 patients with the infection confirmed by PCR, the new test is positive for 240. Among 700 patients without the infection, the new test is negative for 630. What are the sensitivity and specificity of this new rapid test?
Answer: Sensitivity is 80% and specificity is 90%.
Sensitivity is the ability of a test to correctly identify those with the disease (True Positives / (True Positives + False Negatives)). Here, TP = 240 and FN = 300 - 240 = 60. So, Sensitivity = 240 / (240 + 60) = 240 / 300 = 0.80 or 80%. Specificity is the ability of a test to correctly identify those without the disease (True Negatives / (True Negatives + False Positives)). Here, TN = 630 and FP = 700 - 630 = 70. So, Specificity = 630 / (630 + 70) = 630 / 700 = 0.90 or 90%.
- To differentiate a recent (primary) from a past or reactivated cytomegalovirus (CMV) infection, an IgG avidity assay is performed. The assay treats duplicate sample wells with and without a protein denaturant (e.g., urea). A low avidity index, indicative of a recent primary infection, is calculated when:
Answer: the signal in the urea-treated well is significantly lower than the signal in the untreated well.
During a primary immune response, the initially produced IgG antibodies have low avidity (binding strength) for their antigen. In an avidity assay, a denaturing agent like urea is strong enough to disrupt these weak low-avidity antibody-antigen bonds, causing the antibodies to be washed away and resulting in a low signal. In a past infection, affinity maturation has occurred, producing high-avidity IgG. These strong bonds are resistant to urea treatment, so the signal remains high. A low avidity index (ratio of signal with urea / signal without urea) reflects a large drop in signal upon treatment and indicates a recent primary infection.
- A lab wants to confirm the identity of a bacterial isolate using a serological method. They have polyclonal antiserum raised against the whole, heat-killed bacterium. They also have a monoclonal antibody that recognizes a single, highly specific surface epitope. Which reagent would provide a more specific identification and which would be more likely to show cross-reactivity with closely related species?
Answer: More specific: monoclonal. More cross-reactive: polyclonal.
A monoclonal antibody (mAb) is, by definition, specific for a single epitope. This high specificity makes it an excellent tool for precise identification and minimizes the chance of binding to other organisms. A polyclonal antiserum contains a mixture of antibodies that recognize many different epitopes on the target bacterium. Because closely related bacterial species often share some common or structurally similar epitopes, the polyclonal antiserum is much more likely to cross-react with these other species. Therefore, the monoclonal antibody provides higher specificity, while the polyclonal antiserum is more prone to cross-reactivity.
- Two monoclonal antibodies, mAb-A and mAb-B, are generated against a large, multivalent bacterial surface protein. Biacore analysis shows that mAb-A has a higher affinity (Ka) for a single epitope than mAb-B. However, in a functional agglutination assay using whole bacteria, mAb-B is a far more potent agglutinin than mAb-A. Which of the following is the most likely explanation for this observation?
Answer: mAb-B has a higher overall avidity for the multivalent bacterial surface, leading to more stable cross-linking.
This scenario highlights the difference between affinity and avidity. Affinity refers to the strength of binding at a single epitope-paratope interaction. Avidity is the overall, cumulative binding strength of all interactions, which is especially important for multivalent antigens and antibodies. mAb-B may have lower single-site affinity but superior overall avidity, perhaps due to factors like being an IgM pentamer (with 10 binding sites) versus an IgG monomer (with 2), or having better flexibility in its hinge region, allowing for more effective cross-linking of whole bacteria. This superior cross-linking ability results in more potent agglutination.
- A patient's serum is screened for HIV using an ELISA and is found to be reactive. A confirmatory Western blot is performed, which shows a distinct band for the p24 antigen but no bands for gp41 or gp120/160. According to CDC guidelines, what is the correct interpretation of this result and the recommended course of action?
Answer: Indeterminate; the patient should be re-tested in 2-4 weeks to assess for seroconversion.
According to CDC criteria, a Western blot is considered positive for HIV-1 if at least two of the following three bands are present: p24, gp41, and gp120/160. The presence of only one band (in this case, p24) makes the result indeterminate. This pattern can occur in very early infection before the full antibody response has developed. Therefore, the standard recommendation is to collect a new sample in 2-4 weeks to check for the appearance of additional bands (seroconversion). It is not considered a negative result, nor is it sufficient for a positive diagnosis.
- A patient undergoing a medical evaluation for an insurance policy has a positive Rapid Plasma Reagin (RPR) test. A confirmatory Fluorescent Treponemal Antibody Absorption (FTA-ABS) test is negative. The patient is asymptomatic and has a history of systemic lupus erythematosus (SLE). What is the most probable reason for these discrepant serology results?
Answer: The RPR test is a biological false positive due to anti-cardiolipin antibodies associated with the patient's SLE.
The RPR test is a non-treponemal test that detects antibodies to cardiolipin, a lipid released from damaged cells. While present in syphilis, anti-cardiolipin antibodies can also be produced in other conditions, notably autoimmune diseases like SLE, leading to a biological false positive. The FTA-ABS is a treponemal test that detects antibodies specific to Treponema pallidum antigens and is used for confirmation. A negative FTA-ABS with a positive RPR in a patient with SLE strongly suggests the RPR result is a false positive. Treponemal tests like FTA-ABS typically remain positive for life after infection, and they are usually the first to become positive in early infection.
- A laboratory is developing an immunofluorescence assay to detect a viral antigen in tissue sections. They can use a direct method with a single fluorescently-labeled primary antibody or an indirect method with an unlabeled primary antibody followed by a fluorescently-labeled secondary antibody. To achieve the highest possible sensitivity for detecting low amounts of antigen, which method is preferable and why?
Answer: Indirect, because multiple fluorescent secondary antibodies can bind to a single primary antibody, amplifying the signal.
The indirect immunofluorescence method offers higher sensitivity due to signal amplification. Each primary antibody that binds to the target antigen can be bound by multiple fluorescently-labeled secondary antibodies. This multiplication effect results in a much brighter signal than the direct method, where only one fluorescent label is attached to each bound primary antibody. While the indirect method does have more steps and the secondary antibody is a versatile reagent, its primary advantage for sensitivity is signal amplification.
- A tube agglutination test for Brucella abortus antibodies is performed on a patient's serum. Serial dilutions of the serum are tested against a constant amount of Brucella antigen. Following incubation, strong agglutination is observed in tubes with high serum dilutions (e.g., 1:160, 1:320), but no agglutination is seen in tubes with low serum dilutions (e.g., 1:10, 1:20). What is the most likely explanation for this pattern?
Answer: The prozone phenomenon, where an excess of antibody saturates antigen sites and prevents lattice formation.
The prozone phenomenon occurs when the concentration of antibodies is so high that each antigen particle is saturated with individual antibodies, preventing the formation of the antibody-antigen lattice required for visible agglutination. Diluting the serum reduces the antibody concentration to a more optimal ratio with the antigen, allowing agglutination to occur. The postzone phenomenon is caused by antigen excess, which would not be the case here as the antigen amount is constant. Low-avidity antibodies would likely produce weak or no agglutination at all dilutions. While blocking antibodies exist, the classic textbook cause for this specific pattern is prozone.
- A competitive ELISA is used to measure the concentration of a specific hormone in patient serum. In this assay format, microtiter wells are coated with the hormone. Patient serum is incubated in the wells along with a fixed amount of enzyme-labeled anti-hormone antibody. After washing, a colorimetric substrate is added. A patient with a very high level of the hormone is tested. What result is expected?
Answer: A low optical density, because the patient's hormone competes with the coated hormone for binding to the labeled antibody.
In a competitive ELISA for antigen detection, the signal is inversely proportional to the amount of antigen in the sample. The hormone in the patient's sample (free antigen) competes with the hormone coated on the plate for binding to a limited number of enzyme-labeled antibodies. If the patient has a high hormone level, most of the labeled antibodies will bind to the patient's hormone in the solution phase and be washed away. Fewer labeled antibodies will bind to the hormone on the plate, resulting in a low signal (low optical density).
- An indirect immunofluorescence assay (IFA) is performed to detect antibodies against a specific bacterium. A technician performing the assay forgets to add the blocking agent (e.g., bovine serum albumin) after fixing the bacteria to the slide. How would this omission most likely affect the test result?
Answer: It would cause a false-positive or high background signal due to non-specific binding of antibodies.
The blocking agent is a crucial reagent used to cover non-specific binding sites on the solid phase (the glass slide). By omitting the blocking step, these sites remain exposed. Consequently, both the primary and/or the secondary antibodies can bind non-specifically to the slide surface, not just to the target antigen. This results in a high background fluorescence or a false-positive signal, making the test uninterpretable. The omission would not prevent specific binding, but it would add significant non-specific binding.
- A hemagglutination inhibition test is performed on a patient's serum to detect antibodies against influenza virus. A standardized amount of virus is mixed with serial dilutions of the patient's serum, and then a suspension of chicken red blood cells (RBCs) is added. A positive result, indicating the presence of anti-influenza antibodies, would be visualized as:
Answer: A compact button of non-agglutinated RBCs that have settled at the bottom of the well.
When you encounter hemagglutination inhibition (HI) tests, remember that you're looking at a two-step process where antibodies can block viral binding to red blood cells. Influenza viruses naturally agglutinate (clump) chicken RBCs because viral hemagglutinin proteins bind to sialic acid receptors on the RBC surface.
The correct answer is D because when anti-influenza antibodies are present in the patient's serum, they bind to the viral hemagglutinin proteins and prevent the virus from attaching to the RBCs. Without viral binding, the RBCs cannot form clumps and instead settle as a compact button at the bottom of the well. This inhibition of hemagglutination indicates a positive result for antibodies.
Option A describes what happens in a negative result—when no antibodies are present, the virus freely agglutinates the RBCs, creating a diffuse lattice pattern across the well bottom. Option B incorrectly describes a precipitin reaction, which involves antigen-antibody complexes forming visible precipitates, not the mechanism of HI testing. Option C describes hemolysis (RBC destruction), which isn't part of hemagglutination testing and would indicate cellular damage rather than antibody presence.
The key study tip: In HI tests, counterintuitively, inhibition (no clumping) equals a positive antibody result, while agglutination indicates no protective antibodies. Think "antibodies block viral attachment = compact button = positive for immunity." This pattern appears frequently in virology questions about serological testing.
- A laboratory utilizes a latex agglutination test to detect Clostridium difficile toxin in stool samples. The latex particles provided in the kit are coated with anti-toxin antibodies. A positive stool sample is mixed with the reagent. Which term best describes this type of assay and the expected positive result?
Answer: Reverse passive agglutination; visible clumping of the latex particles.
When you encounter questions about agglutination tests, focus on understanding what's being coated with antibodies and what's being detected. This determines both the assay type and the expected result.
In this C. difficile toxin detection test, latex particles are pre-coated with anti-toxin antibodies. When toxin is present in the stool sample, it binds to these antibodies on the latex particles, causing the particles to clump together visibly. This is called "reverse passive agglutination" because the antibodies (not antigens) are attached to the carrier particles, and the target antigen (toxin) is in the test sample. The positive result is visible clumping of the latex particles.
Answer choice A is incorrect because "passive agglutination" typically refers to antigens coated on particles, not antibodies. Also, clearing would indicate a negative result, not positive clumping. Choice B is wrong because this isn't direct agglutination of bacteria—you're detecting soluble toxin, not whole bacterial cells. Choice C misidentifies the assay type; agglutination inhibition would require a different setup where agglutination is prevented rather than promoted.
Remember this pattern: In latex agglutination tests for toxin detection, if antibodies are coated on the particles and you're looking for antigen in the sample, it's reverse passive agglutination. A positive result always means visible clumping occurs because the target molecule successfully bridges the coated particles together.
- In a single radial immunodiffusion (Mancini) assay, the antigen concentration is proportional to the square of the precipitin ring diameter. Standards containing 50 U/mL and 200 U/mL of an antigen produce rings with diameters of 10 mm and 20 mm, respectively. A patient sample tested in the same assay produces a ring with a 15 mm diameter. What is the antigen concentration in the patient's sample?
Answer: 112.5 U/mL
The relationship is C = k d², where C is concentration, d is diameter, and k is a constant. First, find k using a standard. Using the first standard: 50 = k (10)² = 100k, so k = 0.5. (Check with the second standard: 200 = 0.5 (20)² = 0.5 400 = 200. The constant holds). Now, use k to find the patient's concentration: C = 0.5 (15)² = 0.5 225 = 112.5 U/mL. The common mistake is to assume a linear relationship between concentration and diameter (not diameter squared), which would lead to the incorrect answer of 125 U/mL (since 15 mm is halfway between 10 mm and 20 mm, the concentration would be assumed to be halfway between 50 and 200).
